VanLooy J W, Schumacher Robert E, Bhatt-Mehta Varsha
Neonatal-Perinatal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Ann Pharmacother. 2008 Jul;42(7):947-55. doi: 10.1345/aph.1K665. Epub 2008 Jul 1.
Preventing significant oxygen desaturation and hypotension through adequate analgesia and sedation during nonemergent intubation in neonates is desirable. However, in many neonatal intensive care units, elective intubations occur without adequate premedication. There is significant variation in the choice of premedication agent(s) and doses, and an ideal regimen for use during nonemergent intubation has not been developed.
To evaluate the efficacy of an algorithm developed for analgesia and sedation during nonemergent intubation in neonates.
Prospectively collected continuous quality improvement data on a premedication algorithm for nonemergent intubation were analyzed following institutional review board approval. Midazolam 0.1 mg/kg and fentanyl 2 microg/kg (if the patient was not already receiving morphine for sedation) were administered prior to nonemergent intubation. Heart rate, oxygen saturation, respiration rate, mean arterial pressure, and pain scores were recorded at baseline prior to medication administration, during the procedure, and for 2 hours after the procedure. Data during laryngoscopy and until the time of tube taping were obtained from the bedside cardiorespiratory monitor. Additional fentanyl was allowed for more than 3 intubation attempts and rocuronium 0.6 mg/kg was allowed for more than 5 attempts. The physiological changes that occurred over time were compared with baseline. The number of attempts made, time to intubation, and medications used are presented.
Ninety evaluable patients were included. Mean +/- SD birth weight and postnatal age at treatment were 2040 +/- 961 g and 14 +/- 17 days, respectively. Heart rate decreased and oxygen saturation increased significantly (160 vs 154 beats/min, p = 0.01; 96.4% vs 93.8%, p = 0.002, respectively) from baseline to completion of the procedure; however, mean arterial pressure showed no significant difference (44.9 vs 44.7 mm Hg; p = 0.85; n = 68). The number of attempts at intubation were recorded for 66 patients; of those, 52 required 3 or fewer attempts for successful intubation (median, 2). The time to successful intubation was 7.2 +/- 5.6 minutes (recorded in 45 pts.). Average fentanyl and midazolam doses were 1.92 +/- 0.53 microg/kg and 0.096 +/- 0.026 mg/kg, respectively. No patient received rocuronium.
A systematic approach to premedication during nonemergent intubation successfully prevented acute physiological changes.
在新生儿非紧急插管过程中,通过充分的镇痛和镇静来预防明显的氧饱和度下降和低血压是很有必要的。然而,在许多新生儿重症监护病房,选择性插管在没有充分预处理的情况下进行。预处理药物的选择和剂量存在很大差异,尚未制定出非紧急插管期间使用的理想方案。
评估为新生儿非紧急插管制定的镇痛和镇静算法的疗效。
在机构审查委员会批准后,对前瞻性收集的关于非紧急插管预处理算法的持续质量改进数据进行分析。在非紧急插管前给予咪达唑仑0.1mg/kg和芬太尼2μg/kg(如果患者尚未接受吗啡镇静)。在给药前的基线、操作过程中以及操作后2小时记录心率、氧饱和度、呼吸频率、平均动脉压和疼痛评分。喉镜检查期间和直到导管固定时的数据从床边心肺监护仪获取。超过3次插管尝试允许额外使用芬太尼,超过5次尝试允许使用罗库溴铵0.6mg/kg。将随时间发生的生理变化与基线进行比较。列出尝试次数、插管时间和使用的药物。
纳入90例可评估患者。治疗时的平均出生体重和出生后年龄分别为2040±961g和14±17天。从基线到操作完成,心率显著下降,氧饱和度显著上升(分别为160次/分钟对154次/分钟,p = 0.01;96.4%对93.8%,p = 0.002);然而,平均动脉压无显著差异(44.9mmHg对44.7mmHg;p = 0.85;n = 68)。记录了66例患者的插管尝试次数;其中,52例成功插管需要3次或更少尝试(中位数为2次)。成功插管时间为7.2±5.6分钟(记录于45例患者)。芬太尼和咪达唑仑的平均剂量分别为1.92±0.53μg/kg和0.096±0.026mg/kg。没有患者接受罗库溴铵。
非紧急插管期间的系统预处理方法成功预防了急性生理变化。